310 related articles for article (PubMed ID: 25347344)
21. Molecular biological determinations of meningioma progression and recurrence.
Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
24. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
[TBL] [Abstract][Full Text] [Related]
26. Infarction with associated pseudosarcomatous changes mimics anaplasia in otherwise grade I meningiomas.
Bale TA; Benhamida J; Roychoudury S; Villafania L; Wrzolek MA; Bouffard JP; Bapat K; Ladanyi M; Rosenblum MK
Mod Pathol; 2020 Jul; 33(7):1298-1306. PubMed ID: 32047229
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas.
Lekanne Deprez RH; Riegman PH; van Drunen E; Warringa UL; Groen NA; Stefanko SZ; Koper JW; Avezaat CJ; Mulder PG; Zwarthoff EC
J Neuropathol Exp Neurol; 1995 Mar; 54(2):224-35. PubMed ID: 7876890
[TBL] [Abstract][Full Text] [Related]
28. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
29. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
[TBL] [Abstract][Full Text] [Related]
30. NF2 mutations in secretory and other rare variants of meningiomas.
Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A
Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978
[TBL] [Abstract][Full Text] [Related]
31. Genomic profile of human meningioma cell lines.
Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF
PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950
[TBL] [Abstract][Full Text] [Related]
32. Pathological classification and molecular genetics of meningiomas.
Mawrin C; Perry A
J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
[TBL] [Abstract][Full Text] [Related]
33. Genetic changes with prognostic value in histologically benign meningiomas.
Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
[TBL] [Abstract][Full Text] [Related]
35. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
36. Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas.
Koizumi S; Sakai N; Kawaji H; Takehara Y; Yamashita S; Sakahara H; Baba S; Hiramatsu H; Sameshima T; Namba H
J Neurooncol; 2015 Feb; 121(3):549-56. PubMed ID: 25479828
[TBL] [Abstract][Full Text] [Related]
37. Monosomy 7p in meningiomas: a rare constituent of tumor progression.
Henn W; Niedermayer I; Ketter R; Reichardt S; Freiler A; Zang KD
Cancer Genet Cytogenet; 2003 Jul; 144(1):65-8. PubMed ID: 12810258
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic iron deposition is associated with the expression of oxidative DNA damage marker in meningiomas.
Nagaishi M; Yokoo H; Osawa T; Nobusawa S; Tanaka Y; Ikota H; Yoshimoto Y; Nakazato Y
Neuropathology; 2013 Oct; 33(5):526-32. PubMed ID: 23406462
[TBL] [Abstract][Full Text] [Related]
39. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD
Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
[TBL] [Abstract][Full Text] [Related]
40. Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.
Ketter R; Kim YJ; Storck S; Rahnenführer J; Romeike BF; Steudel WI; Zang KD; Henn W
J Neurooncol; 2007 Jun; 83(2):213-21. PubMed ID: 17225936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]